Franck Morschhauser, MD, PhD, on Next Steps for Follicular Lymphoma and Liso-Cel
The professor of hematology at University of Lille and chair of LYSA also discussed what the group will be focusing on in 2024.
Franck Morschhauser, MD, PhD, on Encouraging Data on Second Line Liso-Cel for Follicular Lymphoma
The professor of hematology at University of Lille and chair of LYSA shared updated data from the TRANSCEND-FL trial.